Tomohiko Sekioka Selected Research

gemilukast

10/2015	Effects of ONO-6950, a novel dual cysteinyl leukotriene 1 and 2 receptors antagonist, in a guinea pig model of asthma.
10/2015	Expression of CysLT2 receptors in asthma lung, and their possible role in bronchoconstriction.
8/2015	Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomohiko Sekioka Research Topics

Disease

5	Asthma (Bronchial Asthma) 01/2018 - 08/2015
1	Airway Remodeling 01/2018
1	Anaphylaxis (Anaphylactic Shock) 01/2017

Drug/Important Bio-Agent (IBA)

3	cysteinyl leukotriene receptor 2IBA 01/2018 - 10/2015
3	gemilukastIBA 10/2015 - 08/2015
2	AntigensIBA 01/2018 - 10/2015
2	montelukast (Singulair)FDA Link 01/2017 - 10/2015
2	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 01/2017 - 10/2015
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2017
1	Guanosine Triphosphate (GTP)IBA 01/2017
1	Leukotriene C4IBA 01/2017
1	Leukotriene D4IBA 01/2017
1	cysteinyl-leukotrieneIBA 10/2015

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2018